inDrop™ System selected to generate predictive multi-omic clinical research data for undiagnosed conditions with immune dysfunction CAMBRIDGE, Mass., and MOUNTAIN VIEW, Calif. – 1CellBio Inc., a leading single-cell analysis company serving the biomedical research community, today announced a partnership agreement with the Open Medicine Institute (OMI), a leading independent precision medicine clinical and research organization. […]
HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that the company has been awarded a contract for iQ-Check real-time PCR pathogen detection test kits and the iQ-Check Prep Automation System from the United States Department of Agriculture’s Food Safety and Inspection Service […]
First end-to-end workflow for multi-species screening and identification BASINGSTOKE, England — Thermo Fisher Scientific announced the introduction of a new, complete next generation sequencing (NGS) workflow for multi-species screening and identification for food authenticity. This comes after Oxoid Ltd. (a part of Thermo Fisher Scientific) and SGS MOLECULAR, S.A. signed a global co-marketing and distribution agreement that […]
–CRISPR Therapeutics Gains Additional Rights to MaxCyte’s Cell Engineering Technology to Develop CRISPR/Cas9-Based Cell Therapies in Immuno-Oncology– ZUG, SWITZERLAND, CAMBRIDGE, MASS. and GAITHERSBURG, MD – CRISPR Therapeutics (NASDAQ:CRSP) and MaxCyte today announced the expansion of their existing relationship by entering into a non-exclusive commercial license agreement that will allow CRISPR Therapeutics to deploy MaxCyte’s Flow Electroporation® […]
VaxArray to improve potency testing for MR vaccines with support from Bill & Melinda Gates Foundation BOULDER — InDevR announced today that it will pursue proof of concept development for new VaxArray potency assays for measles (M) and rubella vaccines sponsored by the Bill & Melinda Gates Foundation. The long-term objective is to create in […]
Project to focus on genetic testing technologies to expand access to personalized medicine CHICAGO — Blue Cross Blue Shield Association (BCBSA) and Illumina, Inc. today announced an important partnership to determine the availability and clinical understanding of DNA sequencing technologies, genetic testing and precision medicine across the country in an effort to provide patients with expanded access […]
Project to focus on genetic testing technologies to expand access to personalized medicine Blue Cross Blue Shield Association (BCBSA) and Illumina, Inc. today announced an important partnership to determine the availability and clinical understanding of DNA sequencing technologies, genetic testing and precision medicine across the country in an effort to provide patients with expanded access […]
Following successful European rollout, more customers to benefit from enhanced local sales and support services Oxford, UK. Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced that it has expanded its direct sales of Cytocell Fluorescence In Situ Hybridisation (FISH) products to include the Asia-Pacific (APAC) region. OGT will provide customers in Singapore, Malaysia, Vietnam, Australia, and New Zealand with enhanced local […]
Large-Scale Production of Linear DNA Shows the Best Lot-To-Lot Reproducibility and Sequence Accuracy for Kits Targeting Autoimmunity and Infectious Diseases STONY BROOK, NY. – Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA”), the leader in large-scale PCR-based DNA manufacturing, announced today that LineaRx, Inc. (“LineaRx” or the “Company”) has been providing linear DNA to Technogenetics (Shanghai Kehua Bio-Engineering […]
Expedeon’s proprietary immunoassay technology to be incorporated into Quanterix’ Simoa Planar Immunoassay products Heidelberg, Germany and Cambridge, UK – Expedeon AG (Frankfurt: EXN; ISIN: DE000A1RFM03; Prime Standard) today announced a supply and license agreement with United States based Life Sciences company, Quanterix Corporation. The agreement provides Quanterix access to Expedeon’s breadth of immunoassay technologies for application […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
